Key points are not available for this paper at this time.
Neoadjuvant chemotherapy might be a valuable treatment modality for patients with unresectable stage IVB serous endometrial cancer. Innovative treatments are warranted in this cluster of patients.
Bogani et al. (Mon,) studied this question.